Product Details
Product Name:
Des(benzylpyridyl) Atazanavi |
CAS No.:
1192224-24-0 |
Purity:
99.75% |
Supply Ability:
10g |
Release date:
2024/11/14 |
Product Introduction
Bioactivity
名稱 | Des(benzylpyridyl) Atazanavi |
描述 | The N-dealkylated metabolite (M1) of Atazanavir, a HIV protease inhibitor. |
存儲(chǔ)條件 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
溶解度 | DMSO : 50 mg/mL (93 mM)
|
關(guān)鍵字 | Human immunodeficiency virus | HIV Protease | Des(benzylpyridyl) Atazanavir | metabolite of Atazanavir | HIV protease inhibitor | Inhibitor | inhibit | HIV | HIV-1 infection | Drug Metabolite | Des(benzylpyridyl) Atazanavi |
相關(guān)產(chǎn)品 | Stavudine | 5-Fluorouracil | Inosine pranobex | Emtricitabine | Kaempferol | Dolutegravir intermediate-1 | Dextran sulfate sodium salt (MW 4500-5500) | Lamivudine | Chloroquine phosphate | Tenofovir Disoproxil Fumarate | Decanedioic acid | Tenofovir |
相關(guān)庫(kù) | 經(jīng)典已知活性庫(kù) | 蛋白酶抑制劑庫(kù) | 抗病毒庫(kù) | 抑制劑庫(kù) | NO PAINS 化合物庫(kù) | 已知活性化合物庫(kù) | 抗COVID-19化合物庫(kù) | 抗感染化合物庫(kù) |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
-
CAS:113994-45-9
$483.00 / 1mg
-
-
CAS:199433-70-0
$33.00 / 5mg
Recommended supplier
Product name |
Price |
|
Suppliers |
Update time |
|
$50.00/1kg |
VIP1Y
|
Hebei Zhuanglai Chemical Trading Co.,Ltd
|
2024-05-06 |
|
$9.90/1mg/via |
VIP2Y
|
Wuhan Cell Pharmaceutical Co., Ltd
|
2023-04-11 |
|
$130.00/500mg |
VIP3Y
|
Wuhan Senwayer Century Chemical Co.,Ltd
|
2022-11-02 |